Financial Daily from THE HINDU group of publications
Thursday, Apr 29, 2004
Financial Daily from THE HINDU group of publications Thursday, Apr 29, 2004 |
||
|
|
||
|
Corporate
-
Research & Development Ranbaxy in tripartite pact for new drug discovery Our Bureau
New Delhi , April 28 RANBAXY Laboratories Ltd has entered into collaboration with National Institute of Pharmaceutical Education and Research (NIPER), Mohali and Department of Science & Technology (DST), for research in new drug discovery. Ranbaxy and NIPER had jointly conceived the project titled `Computer Aided Drug Design & Synthesis of novel small molecules as potential anti-asthma agents'. As per the alliance, Ranbaxy and DST will fund NIPER, to synthesise small molecules as anti-asthma drugs. Ranbaxy will screen these molecules and identify candidates for further development. The agreement was signed by Dr C.L. Kaul, Director, NIPER, Dr Kasim Mookhtiar, Vice-President - NDDR, R&D, Ranbaxy, and Dr G.J. Samathanam, Director, DST. According to Dr Mookhtiar, "The Indian pharmaceutical industry is changing rapidly. The impending product patents regime, liberalisation of price controls and structural changes in pharma companies, are going to affect the industry."
More Stories on : Research & Development | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|